BNP/CALL/BRISTOL-MYERS SQUIBB/60/0.1/17.01.25 Stock BNP/CALL/BRISTOL-MYERS SQUIBB/60/0.1/17.01.25
Add to a list
To use this feature you must be a member
Log inSign up

BNP/CALL/BRISTOL-MYERS SQUIBB/60/0.1/17.01.25 Share Price

Warrant

DE000PN5A3V0

Market Closed - Deutsche Boerse AG 01:20:32 29/06/2024 am IST
0.019 EUR -9.52% Intraday chart for BNP/CALL/BRISTOL-MYERS SQUIBB/60/0.1/17.01.25
Current month-9.52%
1 month+137.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart BNP/CALL/BRISTOL-MYERS SQUIBB/60/0.1/17.01.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/24/28 0.019 -9.52%
27/24/27 0.021 -12.50%
26/24/26 0.024 +4.35%
25/24/25 0.023 -4.17%
24/24/24 0.024 -4.00%

Delayed Quote Deutsche Boerse AG

Last update June 29, 2024 at 01:20 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN5A3V
ISINDE000PN5A3V0
Date issued 26/06/2023
Strike 60 $
Maturity 17/01/2025 (202 Days)
Parity 10 : 1
Emission price 1.02 €
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.01 €
Lowest since issue 0.001 €
Delta0.11x
Omega 8.002
Premium45.89x
Gearing70.5x
Moneyness 0.6922
Difference Strike 18.47 $
Difference Strike %+30.78%
Spread 0.072 €
Spread %79.12%
Intrinsic value 0.000000

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53 USD
Average target price
53.19 USD
Spread / Average Target
+28.09%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant